SMTL ID : 8un4.1

KRAS-G13D-GDP in complex with Cpd36 ((E)-1-((3S)-4-(7-(6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl)-6-chloro-8-fluoro-2-(((S)-2-methylenetetrahydro-1H-pyrrolizin-7a(5H)-yl)methoxy)quinazolin-4-yl)-3-methylpiperazin-1-yl)-3-(4-((dimethylamino)methyl)-5-methylpyridin-2-yl)prop-2-en-1-one)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.57 Å
Oligo State
monomer
Ligands
1 x MG: MAGNESIUM ION(Non-covalent)
1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
1 x XV3: (2E)-1-{(3S)-4-[(7M)-7-[6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl]-6-chloro-8-fluoro-2-{[(4R,7aS)-2-methylidenetetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}quinazolin-4-yl]-3-methylpiperazin-1-yl}-3-{4-[(dimethylamino)methyl]-5-methylpyridin-2-yl}prop-2-en-1-one(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Nilewski, C. et al., Structure-Based Design and Evaluation of Reversible KRAS G13D Inhibitors. Acs Med.Chem.Lett. (2024)
Release Date
2023-12-20
Peptides
GTPase KRas: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

GTPase KRas